KIT (c-Kit or SCFR or CD117) Antibody - Western Blot Validated

About the Target

When control selection matters, this antibody helps you analyze KIT (SCFR) in a structured study. KIT is a pathway component whose activation state and localization can change after stimulation. Plan positive and negative controls that match your model system, including perturbations expected to shift the target.

In some datasets and protocols, it is referenced by the gene symbol SCFR.

Research Context

Parallel measurement of upstream inputs and downstream readouts can sharpen interpretation of pathway behavior. Time course design can be decisive when regulation is transient or compartment dependent. Stem or progenitor models may incorporate this target when mapping state transitions and lineage drift.

Consider these angles when interpreting target-level changes:

• interaction patterns within multi-protein complexes
• localization shifts between cytoplasm, membrane, and nucleus
• time-resolved changes following stimulation or inhibition

Variant Considerations

For size-resolved readouts under denaturing conditions, this version helps you focus on expected band patterns and molecular weight regions. This matters because epitope exposure and background can vary with preparation and extraction steps. Include controls that separate true target shifts from matrix or preparation effects.

For challenging targets, pairing KIT measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

Integrate the denaturing-format version into your design so KIT (SCFR) signals can be interpreted alongside matched controls.